FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

371723008: Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197023014 Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1210334010 Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1197023014 Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1197023014 Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1210334010 Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1210334010 Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit Is a Oral metronidazole false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit Is a Product containing tetracycline in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Metronidazole false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tetracycline (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit Is a Product containing bismuth subsalicylate and metronidazole and tetracycline (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bismuth (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bismuth subsalicylate false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antacid (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Existential restriction modifier (core metadata concept)
    Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start